Related Experiment Video
Updated: Aug 6, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Upregulation of ADAM-17 expression in active lesions in multiple sclerosis
Abstract:
ADAM-17, a disintegrin and metalloproteinase, is the major proteinase responsible for the cleavage of membrane-bound tumour necrosis factor (TNF) as well as being an active sheddase of other cytokines, cytokine receptors, growth factors and adhesion molecules. TNF is a major proinflammatory cytokine that has been identified as having a pathogenic role in inflammatory diseases within the CNS including multiple sclerosis (MS). Here we report the cellular origin and distribution of ADAM-17 expression within clinically and neuropathologically confirmed MS and normal control white matter, assessed by immunohistochemistry, western blotting and PCR. ADAM-17 expression was associated with the blood vessel endothelium, activated macrophages/microglia and parenchymal astrocytes in MS white matter. Increased levels of ADAM-17 immunoreactivity were displayed in active lesions with evidence of recent myelin breakdown. Further studies into the functional role of ADAM-17 in the pathogenesis of MS and other inflammatory conditions are required.
Insights
ADAM-17, an enzyme linked to inflammation, is found in the white matter of multiple sclerosis (MS) patients. Its expression increases in active MS lesions, suggesting a role in this central nervous system disease.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- ADAM-17 (a disintegrin and metalloproteinase) cleaves membrane-bound tumor necrosis factor (TNF) and other molecules.
- TNF is a pro-inflammatory cytokine implicated in central nervous system (CNS) inflammatory diseases like multiple sclerosis (MS).
Purpose of the Study:
- To investigate the cellular origin and distribution of ADAM-17 expression in MS white matter.
- To correlate ADAM-17 levels with disease activity in MS.
Main Methods:
- Immunohistochemistry, western blotting, and PCR were used to assess ADAM-17 expression.
- Analysis was performed on white matter from MS patients and normal controls.
Main Results:
- ADAM-17 expression was detected in endothelial cells, macrophages/microglia, and astrocytes in MS white matter.
- Higher ADAM-17 immunoreactivity was observed in active MS lesions with recent myelin breakdown.
Conclusions:
- ADAM-17 is present in various cell types within MS white matter.
- ADAM-17 expression is associated with active demyelination in MS, warranting further investigation into its pathogenic role.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Neural Regulation
Multiple Sclerosis l: Introduction
